Skip to Main content Skip to Navigation
Journal articles

Retrospective Observational Study of Brain MRI Findings in Patients with Acute SARS-CoV-2 Infection and Neurologic Manifestations

Lydia Chougar 1, 2, 3 Natalia Shor 3, 4, 5 Nicolas Weiss 4, 6, 7 Damien Galanaud 1, 2, 3, 5 Delphine Leclercq 3, 4, 5 Bertrand Mathon 1 Samia Belkacem 3, 4, 5 Sebastian Ströer 3 Sonia Burrel 8 David Boutolleau 8 Alexandre Demoule 4, 5 Charlotte Rosso 1 Cécile Delorme 9 Danielle Seilhean 4, 5 Didier Dormont 1, 3, 10 Elise Morawiec 4, 5 Mathieu Raux 10, 1 Sophie Demeret 6, 7 Sophie Gerber 3 Stéphanie Trunet 3 Thomas Similowski 4, 5 Vincent Degos 4, 11 Pierre Rufat 12 Jean-Christophe Corvol 1, 9 Stéphane Lehéricy 1, 2, 3 Nadya Pyatigorskaya 1, 2, 3 
Abstract : Background This study provides a detailed imaging assessment in a large series of patients infected with coronavirus disease 2019 (COVID-19) and presenting with neurologic manifestations. Purpose To review the MRI findings associated with acute neurologic manifestations in patients with COVID-19. Materials and Methods This was a cross-sectional study conducted between March 23 and May 7, 2020, at the Pitié-Salpêtrière Hospital, a reference center for COVID-19 in the Paris area. Adult patients were included if they had a diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with acute neurologic manifestations and referral for brain MRI. Patients with a prior history of neurologic disease were excluded. The characteristics and frequency of different MRI features were investigated. The findings were analyzed separately in patients in intensive care units (ICUs) and other departments (non-ICU). Results During the inclusion period, 1176 patients suspected of having COVID-19 were hospitalized. Of 308 patients with acute neurologic symptoms, 73 met the inclusion criteria and were included (23.7%): thirty-five patients were in the ICU (47.9%) and 38 were not (52.1%). The mean age was 58.5 years ± 15.6 [standard deviation], with a male predominance (65.8% vs 34.2%). Forty-three patients had abnormal MRI findings 2-4 weeks after symptom onset (58.9%), including 17 with acute ischemic infarct (23.3%), one with a deep venous thrombosis (1.4%), eight with multiple microhemorrhages (11.3%), 22 with perfusion abnormalities (47.7%), and three with restricted diffusion foci within the corpus callosum consistent with cytotoxic lesions of the corpus callosum (4.1%). Multifocal white matter-enhancing lesions were seen in four patients in the ICU (5%). Basal ganglia abnormalities were seen in four other patients (5%). Cerebrospinal fluid analyses were negative for SARS-CoV-2 in all patients tested (n = 39). Conclusion In addition to cerebrovascular lesions, perfusion abnormalities, cytotoxic lesions of the corpus callosum, and intensive care unit-related complications, we identified two patterns including white matter-enhancing lesions and basal ganglia abnormalities that could be related to severe acute respiratory syndrome coronavirus 2 infection. © RSNA, 2020 Online supplemental material is available for this article.
Document type :
Journal articles
Complete list of metadata
Contributor : Hal Sorbonne Université Gestionnaire Connect in order to contact the contributor
Submitted on : Wednesday, December 9, 2020 - 10:24:40 AM
Last modification on : Friday, August 5, 2022 - 12:02:16 PM

Links full text



Lydia Chougar, Natalia Shor, Nicolas Weiss, Damien Galanaud, Delphine Leclercq, et al.. Retrospective Observational Study of Brain MRI Findings in Patients with Acute SARS-CoV-2 Infection and Neurologic Manifestations. Radiology, Radiological Society of North America, 2020, 297 (3), pp.E313-E323. ⟨10.1148/radiol.2020202422⟩. ⟨hal-03048013⟩



Record views